Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study

医学 曲妥珠单抗 内科学 肿瘤科 养生 癌症 临床终点 临床试验 乳腺癌
作者
Qian Li,Huiqin Jiang,Hong Li,Rui‐Hua Xu,Lin Shen,Yiyi Yu,Yan Wang,Yuehong Cui,Wei Li,Shan Yu,Tianshu Liu
出处
期刊:Oncotarget [Impact Journals LLC]
卷期号:7 (31): 50656-50665 被引量:44
标识
DOI:10.18632/oncotarget.10456
摘要

// Qian Li 1, * , Huiqin Jiang 1, * , Hong Li 1, * , Ruihua Xu 2 , Lin Shen 3 , Yiyi Yu 1 , Yan Wang 1 , Yuehong Cui 1 , Wei Li 1 , Shan Yu 1 , Tianshu Liu 1 1 Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China 2 Department of Medical Oncology, Sun Yat-Sen University Cancer Center; State Key Laboratory of Oncology in South China, Guangzhou, China 3 Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China * These authors have contributed equally to this work Correspondence to: Tianshu Liu, email: liu.tianshu@zs-hospital.sh.cn Keywords: advanced gastric cancer, HER2, trastuzumab, treatment beyond progression Received: March 18, 2016 Accepted: April 28, 2016 Published: July 07, 2016 ABSTRACT Introduction: Trastuzumab plus chemotherapy is the standard first-line regimen in HER2 positive advanced gastric cancer (AGC), but lack of data in post-progression treatment. So, it is worth evaluating the efficacy of continuing trastuzumab after failure of the first-line trastuzumab based treatment. Methods: 59 patients were enrolled from Zhongshan Hospital Fudan University, Sun Yat-sen University Cancer Center and Peking University Cancer Hospital between September 2012 and Oct 2015. Patients were divided into two groups according to the second line regimens: with or without trastuzumab. The primary endpoint was progression free survival of second line therapy (PFS2). Secondary end points included overall survival (OS), response rate, and adverse events (AEs). Results: Baseline factors were well balanced between two groups. 32 patients treated with trastuzumab plus second line chemotherapy (group A) and 27 patients received chemotherapy alone (group B). The median follow-up time was 7.60 months (range 1.50-32.50). Longer median PFS2 was observed in group A than in group B (3.1 vs 2.0 months, P =0.008). There was no significant differences of median OS2 calculating from the second line therapy (10.5 vs 6.5 months, P =0.172) between two groups. Response rate was 9.3% in group A compared with 3.7% in group B ( P =0.617). AEs were similar in two groups including cardiac safety. Subgroup analysis showed that factors of male, age<65, good performance status, HER2 immunohistochemical (IHC) 2+ and poor response to first line indicated superior PFS2 in patients continuing trastuzumab to those treated with chemotherapy alone. Conclusion: Continuing treatment of trastuzumab beyond first line therapy progression showed effective and safe in AGC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
巴达天使完成签到,获得积分10
刚刚
江三村完成签到 ,获得积分10
刚刚
量子星尘发布了新的文献求助10
18秒前
CyberHamster完成签到,获得积分10
28秒前
xiaohong完成签到,获得积分10
31秒前
朱比特完成签到,获得积分10
32秒前
33秒前
zmuzhang2019发布了新的文献求助10
39秒前
onestepcloser完成签到 ,获得积分0
39秒前
zoe完成签到 ,获得积分10
40秒前
发嗲的慕蕊完成签到 ,获得积分10
41秒前
Linson完成签到,获得积分10
42秒前
顾矜应助赵三岁采纳,获得10
56秒前
yyy2025完成签到,获得积分10
1分钟前
木雨亦潇潇完成签到,获得积分10
1分钟前
香蕉觅云应助nine2652采纳,获得10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
芳华如梦完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
土豆丝完成签到 ,获得积分10
1分钟前
琦琦完成签到,获得积分10
1分钟前
zzzz完成签到,获得积分20
1分钟前
GEZIKU完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
赵三岁发布了新的文献求助10
1分钟前
wwb完成签到,获得积分10
1分钟前
1分钟前
2分钟前
肯德基没有黄焖鸡完成签到 ,获得积分10
2分钟前
能干冰露完成签到,获得积分10
2分钟前
牛奶拌可乐完成签到 ,获得积分10
2分钟前
量子星尘发布了新的文献求助30
2分钟前
周小鱼完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
老张完成签到,获得积分10
2分钟前
2分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038039
求助须知:如何正确求助?哪些是违规求助? 3575756
关于积分的说明 11373782
捐赠科研通 3305574
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022